Neuroimaging in the era of biologically defined Alzheimer's disease and disease-modifying therapy
- DOI
- 10.1016/s1474-4422(26)00285-1
- Published
- 2026-10
- Container
- The Lancet Neurology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s1474-4422-26-00285-1,
title = {Neuroimaging in the era of biologically defined Alzheimer's disease and disease-modifying therapy},
author = {Tammie L S Benzinger and Petrice M Cogswell and Arvin Arani and Aisling M Chaney and Kent Hutson and Matthew F Glasser and Jonathan Graff-Radford and Jon McConathy and Cyrus A Raji and Charlotte Teunissen and Prashanthi Vemuri and Greg Zaharchuk and Clifford R Jack},
year = {2026},
journal = {The Lancet Neurology},
doi = {10.1016/s1474-4422(26)00285-1},
url = {https://doi.org/10.1016/s1474-4422(26)00285-1}
}RIS
TY - JOUR TI - Neuroimaging in the era of biologically defined Alzheimer's disease and disease-modifying therapy AU - Tammie L S Benzinger AU - Petrice M Cogswell AU - Arvin Arani AU - Aisling M Chaney AU - Kent Hutson AU - Matthew F Glasser AU - Jonathan Graff-Radford AU - Jon McConathy AU - Cyrus A Raji AU - Charlotte Teunissen AU - Prashanthi Vemuri AU - Greg Zaharchuk AU - Clifford R Jack PY - 2026 JO - The Lancet Neurology DO - 10.1016/s1474-4422(26)00285-1 UR - https://doi.org/10.1016/s1474-4422(26)00285-1 ER -
APA
Benzinger, T. L. S., Cogswell, P. M., Arani, A., Chaney, A. M., Hutson, K., Glasser, M. F., Graff-Radford, J., McConathy, J., Raji, C. A., Teunissen, C., Vemuri, P., Zaharchuk, G., & Jack, C. R. (2026). Neuroimaging in the era of biologically defined Alzheimer's disease and disease-modifying therapy. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(26)00285-1
Source records
- crossref · retrieved 2026-11-11T01:26:20.278Z